About UroOncology

What is UroOncology?

UroOncology is a peer reviewed, open access journal devoted to the treatment of patients with urological cancer, specifically prostate, transitional cell, renal, adrenal, testicular and penile cancer. Relevant papers in epidemiology, detection, prevention, strategies, diagnosis, treatment, follow up, quality of life, clinical trials and health economics are also considered.

The journal is aimed at surgeons, radiation oncologists, oncologists, pathologists, other healthcare professionals as well as basic researchers.

UroOncology is independent of any society, and its policy of unrestricted editorial independence will be maintained. As an open access, online journal UroOncology is ideally suited to foster the spirit of co-operation between specialties.

Content overview

UroOncology considers the following types of articles:

• Research: reports of data from original research.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. These articles are usually written by opinion leaders that have been invited by the Editorial Board.
• Hypothesis articles: short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence. These articles should outline significant progress in thinking that would also be testable.
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.

Peer review policy

UroOncology operates a closed peer-review process on all manuscripts, which are reviewed by a minimum of two reviewers.

Edited by Leslie Moffat, UroOncology is supported by an international Editorial Board.

Publishing in UroOncology

All articles will be listed in PubMed immediately upon acceptance (after peer review), and will be covered by PubMed Central.

Articles in UroOncology should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.

The following citation:

UroOncology 2004, 2:1

refers to article 1 from volume 2 of the journal.

As an online journal, UroOncology does not have issue numbers. Each volume corresponds to a calendar year.

To keep up to date with the latest articles from UroOncology, why not register to receive alerts? Registration also enables you to customise your subject areas of interest, store your searches, and submit your manuscripts.

Submission of manuscripts

Manuscripts should be submitted electronically to UroOncology using the online submission system. Full details of how to submit a manuscript are given in the instructions for authors.

General journal policies

UroOncology is published  by BioMed Central, an STM (Science, Technology and Medicine) publisher committed to ensuring peer-reviewed biomedical research is Open Access. That means it is freely and universally accessible online, it is archived in at least one internationally recognised free access repository, and its authors retain copyright, allowing anyone to reproduce or disseminate articles, according to the BioMed Central copyright and licence agreement. UroOncology however, has taken this further by making all its content Open Access.

UroOncology's articles are archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and also in repositories at the University of Potsdam in Germany, at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. The journal is also participating in the British Library's e-journals pilot project, and plans to deposit copies of all articles with the British Library.

BioMed Central is working closely with the Thomson Reuters (ISI) to ensure that citation analysis of articles published in UroOncology will be available.

UroOncology is able to deliver summaries of frequently updated content via Really Simple Syndication (RSS) feeds. For more information about RSS feeds see our publisher's website.

For further information about general policies please see the instructions for authors.